Allosite Therapeutics Showcases Novel Integrin Therapies at ASN 2025
Miami, Florida – October 30, 2025 — Allosite Therapeutics, a biotechnology company pioneering allosteric integrin agonists for the treatment...
cGxP
Advertisement
Rapid Micro Biosystems Highlights Growth Direct Automation at Stifel 2025
Lexington, Massachusetts – October 30, 2025 — Rapid Micro Biosystems, Inc. (Nasdaq: RPID), a leader in automated microbial quality...
BBOT Showcases Novel RAS:PI3Kα Breaker at SABCS 2025
South San Francisco, Calif. – October 30, 2025 — BridgeBio Oncology Therapeutics, Inc. (BBOT) announced two poster presentations at...
Ritedose Expands U.S. Nebulized Drug Portfolio with FDA Approval
COLUMBIA, S.C., October 30, 2025 — The Ritedose Corporation has received U.S. Food and Drug Administration (FDA) approval to...
McKesson Expands Cell and Gene Therapy Access Across the U.S.
IRVING, Texas, Oct. 6, 2025 — McKesson Corporation has released new insights highlighting the rapid growth and expanding infrastructure...
Advertisement
